Cas 3094-33-5,(Z,E)-2-acetylamino-3-(3-trifluoromethyl-phenyl)-acrylic acid

3094-33-5

Post Buying Request

Basic information

Product Name: (Z,E)-2-acetylamino-3-(3-trifluoromethyl-phenyl)-acrylic acid
Synonyms: (Z,E)-2-acetylamino-3-(3-trifluoromethyl-phenyl)-acrylic acid
CAS NO:3094-33-5
Molecular Formula:
Molecular Weight: 273.212
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (Z,E)-2-acetylamino-3-(3-trifluoromethyl-phenyl)-acrylic acid(CAS DataBase Reference)
NIST Chemistry Reference: (Z,E)-2-acetylamino-3-(3-trifluoromethyl-phenyl)-acrylic acid(3094-33-5)
EPA Substance Registry System: (Z,E)-2-acetylamino-3-(3-trifluoromethyl-phenyl)-acrylic acid(3094-33-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 3094-33-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

3094-33-5 Suppliers

Recommended suppliers

3094-33-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 3094-33-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,0,9 and 4 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 3094-33:
(6*3)+(5*0)+(4*9)+(3*4)+(2*3)+(1*3)=75
75 % 10 = 5
So 3094-33-5 is a valid CAS Registry Number.

3094-33-5Upstream product

3094-33-5Downstream Products

3094-33-5Relevant academic research and scientific papers

2-OXO-1,2,4,5-TETRAHYDRO-1,3-BENZODIAZEPIN-3-YL-PIPERIDINES USED AS CGRP ANTAGONISTS

-

Page/Page column 73, (2010/11/24)

The invention relates to novel CGRP antagonists of general formula (I), in which B, R1 and R2 are defined as cited in claim 1, to their tautomers, isomers, diastereomers, enantiomers, hydrates, mixtures and salts, in addition to the hydrates of their salts, in particular their physiologically compatible salts, with inorganic or organic acids or bases. The invention also relates to medicaments containing said compounds, to their use and to a method for their production.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 3094-33-5